In this podcast episode, McCall McPherson, a medical professional from the Modern Thyroid Clinic, explores the benefits of GLP-1 agonists, originally developed for diabetes treatment, in aiding weight loss and improving overall health
After accounting for important factors such as age, body mass index (BMI), cancer severity, and other health conditions, the team found that people taking GLP-1 drugs still had a significantly lower risk of death
Briefly, cells were seeded at a density of 510 3 cells/well in 96-well plates and kept for 24 h in incubator
Required dosage modifications based on patient response
Baseline metabolic health plays a significant role